Viewing nowCombinationCozarotan Plus Tablet
Losartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.

MFDS item code 202004055 · Approved 2020.05.29
Treatment of hypertension not controlled with monotherapy
This medication is used for the treatment of patients with hypertension whose blood pressure is not adequately controlled with monotherapy.
○ Adults The usual dose of this medicine is one tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg per day are not recommended. The maximum blood pressure-lowering effect generally occurs approximately 3 weeks after the start of treatment. This medicine may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, initiate treatment with this medicine when the desired effect has not been achieved with monotherapy. 1. Substitution therapy: A combination regimen of individually dose-adjusted losartan potassium and hydrochlorothiazide may be replaced with this medicine. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with one tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of one tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of one tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia even when their blood pressure is controlled at this dose: Treatment may be initiated with one tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily, which can reduce the hydrochlorothiazide dose without reducing the overall blood pressure-lowering effect. Thereafter, continue to assess the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg; if blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of one tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. ○ Patients with renal impairment The usual dose may be administered when creatinine clearance is 30 mL/min or higher. Use of loop diuretics rather than thiazide drugs is preferable in patients with more severe renal impairment; therefore, administration to these patients is not recommended. ○ Patients with hepatic impairment Administration to these patients is not recommended because this medicine cannot provide the initial dose of losartan potassium, 25 mg, for patients with hepatic impairment who require dosage adjustment.
Children (under 18 years of age) Because there is no experience with use in children and adolescents, the losartan-hydrochlorothiazide combination product should not be administered to children or adolescents.
This drug can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, and should be stopped immediately upon confirmation of pregnancy. Patients with an allergy to this medication or its components, those with severely compromised kidney function, problems with the liver or biliary tract, pregnant women, or women who may become pregnant should not take this medication. Those with certain conditions such as hypotension, kidney disease, liver disease, cerebrovascular disorders, and hyperkalemia should use this drug cautiously, and elderly patients should take care as well. When taking this medication, it is important to regularly check blood pressure, kidney function, and electrolyte levels to ensure there are no abnormalities. Side effects such as dizziness, drowsiness, skin rash, cough, indigestion, muscle pain, and anxiety may occur, and if symptoms are severe, a consultation with a physician should be made. This medication can increase potassium levels, so it is important not to take potassium supplements or potassium-containing alternative salts without consulting a physician. Additionally, excessive sun exposure can increase the risk of skin cancer, so patients should take care of sun protection and report any new skin lesions immediately to a doctor. This drug may interact with other antihypertensive medications, diuretics, and antidiabetic agents, so any other medications being taken should be reported. Caution is advised when driving or operating machinery as dizziness or drowsiness may occur. The safety of this medication has not been established for children and adolescents, hence it is not used in this population. This medication should be stored in its original container and kept out of reach of children, and dosing should be strictly followed as directed by a physician.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that protects it from light and should use an airtight container that allows for good air circulation. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius.
Yellow oval film-coated tablets
Bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Yuhan
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd. ) Yuyoung Pharmaceutical
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kolon Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.